Page last updated: 2024-10-16

gamma-aminobutyric acid and Nasal Diseases

gamma-aminobutyric acid has been researched along with Nasal Diseases in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"Gabapentin (Neurontin) was then started with improvement at 1800 mg per day."5.31SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000)
"All subject's Migraine Disability Assessment Scale and VAS scores were compared."1.36Rhinologic evaluation in patients with primary headache. ( Cabalar, M; Gurer, E; Kayhan, FT; Sayin, I; Yayla, V; Yazici, ZM, 2010)
"Gabapentin (Neurontin) was then started with improvement at 1800 mg per day."1.31SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yazici, ZM1
Cabalar, M1
Sayin, I1
Kayhan, FT1
Gurer, E1
Yayla, V1
Graff-Radford, SB1

Other Studies

2 other studies available for gamma-aminobutyric acid and Nasal Diseases

ArticleYear
Rhinologic evaluation in patients with primary headache.
    The Journal of craniofacial surgery, 2010, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Amines; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Endoscopy;

2010
SUNCT syndrome responsive to gabapentin (Neurontin).
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:5

    Topics: Acetates; Amines; Analgesics; Conjunctival Diseases; Cyclohexanecarboxylic Acids; Gabapentin; gamma-

2000